ArticlebioRxiv : the preprint server for biology2020
An engineered receptor-binding domain improves the immunogenicity of multivalent SARS-CoV-2 vaccines.
Brian D Quinlan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it